腫瘍/がん治療薬（抗がん剤） のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Oncology & Cancer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16266 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

腫瘍/がん治療薬（抗がん剤） 市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の腫瘍/がん治療薬（抗がん剤） の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の腫瘍/がん治療薬（抗がん剤） の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 腫瘍/がん治療薬（抗がん剤） 市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・化学療法、標的療法、免疫療法（生物学的製剤）、ホルモン療法、その他 用途別セグメントは次のように区分されます。 ・血液がん、乳がん、胃腸がん、前立腺がん、呼吸器/肺がん、その他 世界の腫瘍/がん治療薬（抗がん剤） 市場の主要な市場プレーヤーは以下のとおりです。 ・Roche、Celgene、Novartis、Bristol-Myers Squibb、Johnson & Johnson、Merck & Co.、AstraZeneca、Pfizer、Amgen、Eli Lilly、AbbVie、Takeda、Astellas、Ipsen、Sanofi、Bayer、Biogen Idec、Teva、Otsuka、Eisai、Merck KGaA、Gilead Sciences 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、腫瘍/がん治療薬（抗がん剤） 製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な腫瘍/がん治療薬（抗がん剤） メーカーの企業概要、2019年～2021年までの腫瘍/がん治療薬（抗がん剤） の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な腫瘍/がん治療薬（抗がん剤） メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別腫瘍/がん治療薬（抗がん剤） の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの腫瘍/がん治療薬（抗がん剤） の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での腫瘍/がん治療薬（抗がん剤） 市場予測を収録しています。 ・第12、13、14章では、腫瘍/がん治療薬（抗がん剤） の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Roche、Celgene、Novartis、Bristol-Myers Squibb、Johnson & Johnson、Merck & Co.、AstraZeneca、Pfizer、Amgen、Eli Lilly、AbbVie、Takeda、Astellas、Ipsen、Sanofi、Bayer、Biogen Idec、Teva、Otsuka、Eisai、Merck KGaA、Gilead Sciences ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、標的療法、免疫療法（生物学的製剤）、ホルモン療法、その他 ・用途別分析2016年-2026年：血液がん、乳がん、胃腸がん、前立腺がん、呼吸器/肺がん、その他 ・腫瘍/がん治療薬（抗がん剤） の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍/がん治療薬（抗がん剤） のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍/がん治療薬（抗がん剤） のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍/がん治療薬（抗がん剤） の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍/がん治療薬（抗がん剤） の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Oncology & Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oncology & Cancer Drugs size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Oncology & Cancer Drugs market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others

Market segment by Application can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others

The key market players for global Oncology & Cancer Drugs market are listed below:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oncology & Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology & Cancer Drugs, with price, sales, revenue and global market share of Oncology & Cancer Drugs from 2019 to 2021.
Chapter 3, the Oncology & Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology & Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oncology & Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oncology & Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Oncology & Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology & Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology & Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Global Oncology & Cancer Drugs Market Size & Forecast
1.4.1 Global Oncology & Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Oncology & Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Oncology & Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
1.5 Global Oncology & Cancer Drugs Production Capacity Analysis
1.5.1 Global Oncology & Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Oncology & Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology & Cancer Drugs Market Drivers
1.6.2 Oncology & Cancer Drugs Market Restraints
1.6.3 Oncology & Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology & Cancer Drugs Product and Services
2.1.4 Roche Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Celgene
2.2.1 Celgene Details
2.2.2 Celgene Major Business
2.2.3 Celgene Oncology & Cancer Drugs Product and Services
2.2.4 Celgene Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Oncology & Cancer Drugs Product and Services
2.3.4 Novartis Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
2.4.4 Bristol-Myers Squibb Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Oncology & Cancer Drugs Product and Services
2.5.4 Johnson & Johnson Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Oncology & Cancer Drugs Product and Services
2.6.4 Merck & Co. Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Oncology & Cancer Drugs Product and Services
2.7.4 AstraZeneca Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Oncology & Cancer Drugs Product and Services
2.8.4 Pfizer Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Oncology & Cancer Drugs Product and Services
2.9.4 Amgen Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Oncology & Cancer Drugs Product and Services
2.10.4 Eli Lilly Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 AbbVie
2.11.1 AbbVie Details
2.11.2 AbbVie Major Business
2.11.3 AbbVie Oncology & Cancer Drugs Product and Services
2.11.4 AbbVie Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Oncology & Cancer Drugs Product and Services
2.12.4 Takeda Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Astellas
2.13.1 Astellas Details
2.13.2 Astellas Major Business
2.13.3 Astellas Oncology & Cancer Drugs Product and Services
2.13.4 Astellas Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Ipsen
2.14.1 Ipsen Details
2.14.2 Ipsen Major Business
2.14.3 Ipsen Oncology & Cancer Drugs Product and Services
2.14.4 Ipsen Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Sanofi
2.15.1 Sanofi Details
2.15.2 Sanofi Major Business
2.15.3 Sanofi Oncology & Cancer Drugs Product and Services
2.15.4 Sanofi Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Bayer
2.16.1 Bayer Details
2.16.2 Bayer Major Business
2.16.3 Bayer Oncology & Cancer Drugs Product and Services
2.16.4 Bayer Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Biogen Idec
2.17.1 Biogen Idec Details
2.17.2 Biogen Idec Major Business
2.17.3 Biogen Idec Oncology & Cancer Drugs Product and Services
2.17.4 Biogen Idec Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Teva
2.18.1 Teva Details
2.18.2 Teva Major Business
2.18.3 Teva Oncology & Cancer Drugs Product and Services
2.18.4 Teva Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Otsuka
2.19.1 Otsuka Details
2.19.2 Otsuka Major Business
2.19.3 Otsuka Oncology & Cancer Drugs Product and Services
2.19.4 Otsuka Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Eisai
2.20.1 Eisai Details
2.20.2 Eisai Major Business
2.20.3 Eisai Oncology & Cancer Drugs Product and Services
2.20.4 Eisai Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Merck KGaA
2.21.1 Merck KGaA Details
2.21.2 Merck KGaA Major Business
2.21.3 Merck KGaA Oncology & Cancer Drugs Product and Services
2.21.4 Merck KGaA Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Oncology & Cancer Drugs Product and Services
2.22.4 Gilead Sciences Oncology & Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oncology & Cancer Drugs Sales by Manufacturer
3.1 Global Oncology & Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oncology & Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oncology & Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology & Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Oncology & Cancer Drugs Manufacturer Market Share
3.5 Global Oncology & Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oncology & Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology & Cancer Drugs Market Size by Region
4.1.1 Global Oncology & Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Oncology & Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Oncology & Cancer Drugs Revenue (2016-2026)
4.3 Europe Oncology & Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Oncology & Cancer Drugs Revenue (2016-2026)
4.5 South America Oncology & Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Oncology & Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oncology & Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Oncology & Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Oncology & Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oncology & Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Oncology & Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Oncology & Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oncology & Cancer Drugs Sales by Type (2016-2026)
7.2 North America Oncology & Cancer Drugs Sales by Application (2016-2026)
7.3 North America Oncology & Cancer Drugs Market Size by Country
7.3.1 North America Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Oncology & Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology & Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Oncology & Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Oncology & Cancer Drugs Market Size by Country
8.3.1 Europe Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Oncology & Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oncology & Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Oncology & Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Oncology & Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology & Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oncology & Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oncology & Cancer Drugs Sales by Type (2016-2026)
10.2 South America Oncology & Cancer Drugs Sales by Application (2016-2026)
10.3 South America Oncology & Cancer Drugs Market Size by Country
10.3.1 South America Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Oncology & Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology & Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Oncology & Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Oncology & Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology & Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oncology & Cancer Drugs Typical Distributors
12.3 Oncology & Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Oncology & Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oncology & Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Oncology & Cancer Drugs Product and Services
Table 6. Roche Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Celgene Basic Information, Manufacturing Base and Competitors
Table 8. Celgene Major Business
Table 9. Celgene Oncology & Cancer Drugs Product and Services
Table 10. Celgene Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Oncology & Cancer Drugs Product and Services
Table 14. Novartis Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
Table 18. Bristol-Myers Squibb Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Oncology & Cancer Drugs Product and Services
Table 22. Johnson & Johnson Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 24. Merck & Co. Major Business
Table 25. Merck & Co. Oncology & Cancer Drugs Product and Services
Table 26. Merck & Co. Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Major Business
Table 29. AstraZeneca Oncology & Cancer Drugs Product and Services
Table 30. AstraZeneca Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Oncology & Cancer Drugs Product and Services
Table 34. Pfizer Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Amgen Basic Information, Manufacturing Base and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Oncology & Cancer Drugs Product and Services
Table 38. Amgen Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 40. Eli Lilly Major Business
Table 41. Eli Lilly Oncology & Cancer Drugs Product and Services
Table 42. Eli Lilly Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Major Business
Table 45. AbbVie Oncology & Cancer Drugs Product and Services
Table 46. AbbVie Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Oncology & Cancer Drugs Product and Services
Table 50. Takeda Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Astellas Basic Information, Manufacturing Base and Competitors
Table 52. Astellas Major Business
Table 53. Astellas Oncology & Cancer Drugs Product and Services
Table 54. Astellas Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Ipsen Basic Information, Manufacturing Base and Competitors
Table 56. Ipsen Major Business
Table 57. Ipsen Oncology & Cancer Drugs Product and Services
Table 58. Ipsen Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Sanofi Basic Information, Manufacturing Base and Competitors
Table 60. Sanofi Major Business
Table 61. Sanofi Oncology & Cancer Drugs Product and Services
Table 62. Sanofi Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Bayer Basic Information, Manufacturing Base and Competitors
Table 64. Bayer Major Business
Table 65. Bayer Oncology & Cancer Drugs Product and Services
Table 66. Bayer Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Idec Major Business
Table 69. Biogen Idec Oncology & Cancer Drugs Product and Services
Table 70. Biogen Idec Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Teva Basic Information, Manufacturing Base and Competitors
Table 72. Teva Major Business
Table 73. Teva Oncology & Cancer Drugs Product and Services
Table 74. Teva Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Otsuka Basic Information, Manufacturing Base and Competitors
Table 76. Otsuka Major Business
Table 77. Otsuka Oncology & Cancer Drugs Product and Services
Table 78. Otsuka Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Eisai Basic Information, Manufacturing Base and Competitors
Table 80. Eisai Major Business
Table 81. Eisai Oncology & Cancer Drugs Product and Services
Table 82. Eisai Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 84. Merck KGaA Major Business
Table 85. Merck KGaA Oncology & Cancer Drugs Product and Services
Table 86. Merck KGaA Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 88. Gilead Sciences Major Business
Table 89. Gilead Sciences Oncology & Cancer Drugs Product and Services
Table 90. Gilead Sciences Oncology & Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Global Oncology & Cancer Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 92. Global Oncology & Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 93. Market Position of Manufacturers in Oncology & Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 94. Global Oncology & Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 95. Head Office and Oncology & Cancer Drugs Production Site of Key Manufacturer
Table 96. Oncology & Cancer Drugs New Entrant and Capacity Expansion Plans
Table 97. Oncology & Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 98. Global Oncology & Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 99. Global Oncology & Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 100. Global Oncology & Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 101. Global Oncology & Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 102. Global Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 103. Global Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 104. Global Oncology & Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 105. Global Oncology & Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 106. Global Oncology & Cancer Drugs Price by Type (2016-2021e) & (US$/Unit)
Table 107. Global Oncology & Cancer Drugs Price by Type (2021-2026) & (US$/Unit)
Table 108. Global Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 109. Global Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 110. Global Oncology & Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 111. Global Oncology & Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 112. Global Oncology & Cancer Drugs Price by Application (2016-2021e) & (US$/Unit)
Table 113. Global Oncology & Cancer Drugs Price by Application (2021-2026) & (US$/Unit)
Table 114. North America Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 115. North America Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 116. North America Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 117. North America Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 118. North America Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 119. North America Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 120. North America Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 121. North America Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 122. Europe Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 123. Europe Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 124. Europe Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 125. Europe Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 126. Europe Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 127. Europe Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 128. Europe Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 129. Europe Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 130. Asia-Pacific Oncology & Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 131. Asia-Pacific Oncology & Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 132. Asia-Pacific Oncology & Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 133. Asia-Pacific Oncology & Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 134. Asia-Pacific Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 135. Asia-Pacific Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 136. Asia-Pacific Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 137. Asia-Pacific Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 138. South America Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 139. South America Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 140. South America Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 141. South America Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 142. South America Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 143. South America Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 144. South America Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 145. South America Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 146. Middle East & Africa Oncology & Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 147. Middle East & Africa Oncology & Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 148. Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 149. Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 150. Middle East & Africa Oncology & Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 151. Middle East & Africa Oncology & Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 152. Middle East & Africa Oncology & Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 153. Middle East & Africa Oncology & Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 154. Direct Channel Pros & Cons
Table 155. Indirect Channel Pros & Cons
Table 156. Oncology & Cancer Drugs Typical Distributors
Table 157. Oncology & Cancer Drugs Typical Customers
List of Figures
Figure 1. Oncology & Cancer Drugs Picture
Figure 2. Global Oncology & Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Targeted Therapy
Figure 5. Immunotherapy (Biologic Therapy)
Figure 6. Hormonal Therapy
Figure 7. Others
Figure 8. Global Oncology & Cancer Drugs Sales Market Share by Application in 2020
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory/Lung Cancer
Figure 14. Others
Figure 15. Global Oncology & Cancer Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Oncology & Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Oncology & Cancer Drugs Sales (2016-2026) & (K Units)
Figure 18. Global Oncology & Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
Figure 19. Global Oncology & Cancer Drugs Production Capacity (2016-2026) & (K Units)
Figure 20. Global Oncology & Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Oncology & Cancer Drugs Market Drivers
Figure 22. Oncology & Cancer Drugs Market Restraints
Figure 23. Oncology & Cancer Drugs Market Trends
Figure 24. Global Oncology & Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 25. Global Oncology & Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 26. Oncology & Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Oncology & Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Oncology & Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Oncology & Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 30. Global Oncology & Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 31. North America Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Europe Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 34. South America Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Oncology & Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 36. Global Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 37. Global Oncology & Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 38. Global Oncology & Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
Figure 39. Global Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 40. Global Oncology & Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 41. Global Oncology & Cancer Drugs Price by Application (2016-2026) & (US$/Unit)
Figure 42. North America Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 43. North America Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 44. North America Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 45. North America Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 46. United States Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 50. Europe Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 51. Europe Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 52. Europe Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Oncology & Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Oncology & Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 62. China Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Oncology & Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Oncology & Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source

---